Trading Statement

RNS Number:2936P
Jourdan PLC
04 March 2008



Embargoed for 2.00pm on 4 March 2008





                                  Jourdan plc
                          ("Jourdan" or the "Company")

                   Trading update and Business Restructuring


Jourdan's results for the six months to 31 December 2007 will be announced in
the week commencing 10 March 2008.  As indicated at the Company's AGM on 24
October trading in the current financial year has varied across the group
although the Company is expected to report that further progress has been made
and this will be reflected in the interim results.  At the Company's AGM,
Chairman David Abell stated that after a strong first quarter "order intake for
those businesses affected by the high street were proving disappointing.
Suncrest relies for a large part of its business on house building and
construction where order intake has been particularly poor."



As a result of continuing poor trading at its Suncrest  subsidiary, and in
particular, the cancellation of a significant order by Suncrest's major
customer, the board announces that it proposes to downsize the business at its
Peterlee facility so as to discontinue the mantelpiece, electric suites and fire
operations and focus Suncrest's operations on the Corby trouser press business.
The Company is consulting with its workforce in this regard and contemplates
that the balance of the business will be transferred from the leasehold factory
in Peterlee to adjacent premises owned by Jourdan.  As a consequence, the
Company anticipates that a substantial non-recurring provision will be required
in the second half year to 30 June 2008.



Jourdan's medical packaging businesses, Westfield Medical Ltd ("Westfield") and
Clinipak Ltd ("Clinipak") continue to prosper with sales and profits ahead of
both budget and up on last year.  More emphasis will be placed on the expansion
of Westfield and Clinipak.  The first phase of this expansion will be Clinipak's
move to new, larger premises within a few miles of its existing site at Bourne
End.



Enquiries:



Jourdan plc                               01476 403456
David Abell, Chairman

Charles Stanley Securities                020 7149 6000
Nominated Adviser
Russell Cook / Carl Holmes




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

TSTUUUBPWUPRGUC